Collaboration - February 12, 2019
Our Nobel Prize issue is out!
Three of the 2018 Nobel Prizes have connections to life sciences, giving us the opportunity to learn more about immune checkpoint therapy, optical tweezers, chirped pulse amplification, directed evolution of enzymes and phage display. We have also had the privilege to speak to eight Laureates, taking part in the lives and careers of eight different […]
Collaboration - January 15, 2019
Swedish & Norwegian researchers have found a measuring tool for optimal antibody effectiveness
Using DNA origami – DNA-based design of precise nanostructures – scientists at Karolinska Institutet in Sweden and at University of Oslo, Norway, have been able to demonstrate the most accurate distance between densely packed antigens in order to get the strongest bond to antibodies in the immune system. The study, which is published in the […]
Collaboration - December 21, 2018
Season’s Greetings from Nordic Life Science
We would like to thank our readers, subscribers and collaboration partners for a fruitful, eventful and fun 2018, and we wish you all a most wonderful holiday season! Nordic Life Science will be back on January 2nd to provide you with the latest news from our exciting life science industry! Until then, here are some […]
Collaboration - December 19, 2018
A new German-Scandinavian life science network project
A new EU project in the program area Öresund-Kattegatt-Skagerak (ÖKS) has been approved. Hanseatic League of Science (HALOS) will build a collaboration between Hamburg and South-West Scandinavia, bring together the four research facilities MAX IV, ESS, DESY and European XFEL, and create a centre for integrated, world-leading Life Science innovation and research. 3.6 million EUR […]
Collaboration - December 18, 2018
Novo Nordisk and Staten Biotechnology collaborate
Staten Biotechnology and Novo Nordisk have announced that they have entered into a collaboration and exclusive option agreement to develop novel therapeutics for the treatment of hypertriglyceridaemia. Under the collaboration agreement, Novo Nordisk will provide research and development (R&D) funding and support for Staten to develop its lead asset STT-5058 for treatment of dyslipidaemia. “Novo […]
Collaboration - December 14, 2018
Thinking outside the box in Umeå
If any city could lay claim to the title of Sweden’s intellectual capital, Umeå would be it. Located in northeastern Sweden and home to about 120 000 people - and growing – Umeå made its mark in the life sciences’ field in the 1980s with work in molecular biology. That research drew the attention of […]
